mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.4 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.4 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.4 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.044 |
0.4 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.4 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.4 |